Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action

References

• Rayar AM, Lagarde N, Ferroud C, Zagury JF, Montes M, Veitia MS. Update on COX-2 selective inhibitors. Curr. Top. Med. Chem. 17(26), 2935–2956 (2017).
   PubMed Web of Science ®Google Scholar
• Gedawy EM, Kassab AE, Kerdawy AM. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Eur. J. Med. Chem. 189, 112066 (2020).
   PubMed Web of Science ®Google Scholar
• Chaiamnuay S, Allison JJ, Curtis JR. Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs. Am. J. Health Syst. Pharm. 63(19), 1837–1851 (2006).
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. Mechanism of action of nonsteroidal antiinflammatory drugs. Am. J. Med. 104(3A), 2S–8S (1998).
   PubMedGoogle Scholar
• Zeilhofer HU. Prostanoids in nociception and pain. Biochem. Pharmacol. 73(2), 165–174 (2007).
   PubMed Web of Science ®Google Scholar
• Ryn JV, Trummlitz G, Pairet M. COX-2 selectivity and inflammatory processes. Current. Med. Chem. 7(11), 1145–1161 (2000).
   PubMed Web of Science ®Google Scholar
• Bekhit AA, Farghaly AM, Shafik RM et al. Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents. Bioorg. Chem. 77, 38–46 (2018).
   PubMed Web of Science ®Google Scholar
• Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 52, 13–23 (1996).
   PubMed Web of Science ®Google Scholar
• Bailey DB, Mitchell JA, Warner TD. COX-2 in cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 26(5), 956–958 (2006).
   PubMed Web of Science ®Google Scholar
• Mason RP, Walter MF, Day CA, Jacob RF. A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and nsaids. Subcell. Biochem. 42, 175–190 (2007).
   PubMedGoogle Scholar
• Lawson FC, Crofford LJ. Cyclooxygenase inhibition and thrombogenicity. Am. J. Med. 110(3), 28–32 (2001).
   PubMedGoogle Scholar
• Kajita S, Ruebel KH, Casey MB, Nakamura N, loyd RV. Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth. Mod. Pathol. 18(3), 221–227 (2005).
   PubMedGoogle Scholar
• Sharma S, Kumar D, Singh G, Monga V, Kumar B. Recent advancements in the development of heterocyclic antiinflammatory agents. Eur. J. Med. Chem. 200, 112438 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao Z, Zhou C. Recent advance in oxazole-based medicinal chemistry. Eur. J. Med. Chem. 144, 444–492 (2018).
   PubMed Web of Science ®Google Scholar
• Khudhair MA, Mahdi MF, Khan AK, AbdRazik BM. Molecular modeling, drug design and binding evaluation of new oxazole derivatives as cyclooxygenase inhibitors. Egypt. J. Chem. 64(9), 5101–5109 (2021).
   Web of Science ®Google Scholar
• Mohamed LW, El-Badry OM, El-Ansary AK, Ismael A. Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors. Bioorg. Chem. 72, 308–314 (2017).
   PubMed Web of Science ®Google Scholar
• Eren G, Ünlü S, Nuñez MT et al. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorg. Med. Chem. 18(17), 6367–6376 (2010).
   PubMed Web of Science ®Google Scholar
• Shakya AK, Kaur A, Al-Najjar BO, Naik RR. Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as on-steroidal anti-inflammatory agents. Saudi Pharm. J. 24(5), 616–624 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou XP, Zhang M, Sun W et al. Design, synthesis, and in-vivo evaluation of 4,5-diaryloxazole as novel nonsteroidal anti-inflammatory drug. Biol. Pharm. Bull. 32(12), 1986–1990 (2009).
   PubMed Web of Science ®Google Scholar
• Navidpour L, Shadnia H, Shafaroodi H, Amini M, Dehpourd AR, Shafieea A. Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors. Bioorg. Med. Chem. 15(5), 1976–1982 (2007).
   PubMed Web of Science ®Google Scholar
• Hassanein HH, Khalifa MM, El-Samaloty ON, Abd El-Rahim M, Taha RA, Ismail MMF. Synthesis and biological evaluation of novel imidazolone derivatives as potential COX-2 inhibitors. Arch. Pharm. Res. 31(5), 562–568 (2008).
   PubMed Web of Science ®Google Scholar
• Sethia R, Jainb S, Aroraa S, Sainib D, Jain N. Synthesis, characterization and molecular docking studies of novel N-(benzimidazol-1-ylmethyl)-4-chlorobenzamide analogues for potential anti-inflammatory and antimicrobial activity. Antiinflamm. Antiallergy Agents Med. Chem. 17(1), 16–31 (2018).
   PubMedGoogle Scholar
• Zala SP, Badmanaban R, Sen DJ, Patel CN. Synthesis and biological evaluation of 2,4,5-triphenyl-1H-imidazole-1-yl derivatives. J. Appl. Pharm. Sci. 2(7), 202–208 (2012).
   Google Scholar
• Gaba M, Singh S, Mohan C et al. Design, synthesis and pharmacological evaluation of gastroprotective anti-inflammatory analgesic agents based on dual oxidative stress cyclooxygenase inhibition. Antiinflamm. Antiallergy Agents Med. Chem. 19(3), 268–290 (2020).
   PubMedGoogle Scholar
• Puratchikodya A, Doble M. Antinociceptive and antiinflammatory activities and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles. Bioorg. Med. Chem. 15(2), 1083–1090 (2007).
   PubMed Web of Science ®Google Scholar
• Navidpour L, Shafaroodi H, Abdi K et al. Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg. Med. Chem. 14(8), 2507–2517 (2006).
   PubMed Web of Science ®Google Scholar
• Carullo G, Galligano F, Aiello F. Structure–activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors. Med. Chem. Commun. 8(3), 492–500 (2017).
   Google Scholar
• Song Y, Connor DT, Doubleday R et al. Synthesis, structure–activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. thiazolone and oxazolone series. J. Med. Chem. 42(7), 1151–1160 (1999).
   PubMed Web of Science ®Google Scholar
• Zarghi A, Arfaei S. Selective COX-2 inhibitors: a review of their structure–activity relationships. Iran. J. Pharm. Res. 10(4), 655–683 (2011).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Elshemy HAH, Azoz AA. 1-(4-Methane (amino) sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines / pyrazoles as potential anti-inflammatory agents. Bioorg. Chem. 63, 13–23 (2015).
   PubMed Web of Science ®Google Scholar
• Dundar Y, Unlu S, Banoglu E et al. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors. Eur. J. Med. Chem. 44(5), 1830–1837 (2009).
   PubMed Web of Science ®Google Scholar
• Shaaban MA, Kamal AM, Faggal SI et al. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors. Arch. Pharm. 353(11), 1–17 (2020).
   Web of Science ®Google Scholar
• Hawkey CJ. COX-2 inhibitors. Lancet 353(9149), 307–314 (1999).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Abdelall EKA, Fadaly WAA, Kamel GM. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors. Bioorg. Med. Chem. Lett. 26(2), 406–412 (2016).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Fadaly WAA. New 1,2-diaryl-4-substituted-benzylidene-5-4H imidazolone derivatives. Bioorg. Chem. 72, 123–129 (2017).
   PubMed Web of Science ®Google Scholar
• Michaux C, Charlier C. Structural approach for COX-2 inhibition. Mini-Rev. Med. Chem. 4(6), 603–615 (2004).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Abdelall EKA, Labib MB, Fadaly WAA, Zidan TH. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: anti-inflammatory activity, histopatholgical profile and in-silico studies. Bioorg. Chem. 105, 104418 (2020).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Fadaly WAA, Elshaier YAMM, Ali WAM, Kamel GM. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorg. Chem. 77, 568–578 (2018).
   PubMed Web of Science ®Google Scholar
• Abdellatif KRA, Abdelgawad MA, Labib MB, Zidan TH. Synthesis and biological evaluation of new diarylpyrazole and triarylimidazoline derivatives as selective COX-2 inhibitors. Arch. Pharm. Chem. Life Sci. 350(8), 1600386 (2017).
   Web of Science ®Google Scholar
• Ghanim AM, Abdel-wahab HAA. Synthesis, biological evaluation and molecular docking of diarylimidazole derivatives as new potential anti-inflammatory agents targeting COX-2 enzyme. Bull. Pharm. Sci. Assiut. Univ. 46(1), 235–250 (2023).
   Google Scholar
• Husain A, Alasmari AF, Azmi SNH et al. Rational drug design, synthesis, and in vivo biological activity of new indolyl–imidazolone hybrids as potential and safer non-steroidal anti-inflammatory agents. J. King Saud Univ. Sci. 34(4), 102023 (2022).
   Web of Science ®Google Scholar
• Shahrasbia M, Movahedb MA, Dadrasa OG, Daraeic B, Zarghib A. Design, synthesis and biological evaluation of new imidazo[2,1-b] thiazole derivatives as selective COX-2 inhibitors. Iran. J. Pharm. Res. 17(4), 1288–1296 (2018).
   PubMed Web of Science ®Google Scholar
• Cui WL, Wang MH, Yang YH, Wang JY. Effect of different substituents on the fluorescence properties of precursors of synthetic GFP analogues and a polarity-sensitive lipid droplet probe with AIE properties for imaging cells and zebrafish. Org. Biomol. Chem. 21(14), 2960–2967 (2023).
   PubMed Web of Science ®Google Scholar
• Jean-Claude P, Lazszlo B, Pierre H, Jacques D. Phenylalaninderivate, Verfahren zu deren Herstellung und diese Verbindungen Enthaltende Pharmazeutische Zusammensetzungen. SCIENCE UNION - DE2310827, 1973, A1[Chem.Abstr., vol. 79, # 146848][Chem.Abstr., vol. 79, # 146848]). https://worldwide.espacenet.com/patent/search?q=pn%3DGB1366554A
   Google Scholar
• El-Araby M, Omar A, Hassanein HH, El-Helby AH, Abdel-Rahman AA. Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives. Molecule 17(10), 12262–12275 (2012).
   PubMed Web of Science ®Google Scholar
• Winter CA, Risely EA, Nuss GM. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111(3), 544–547 (1962).
   PubMed Web of Science ®Google Scholar
• Naumov RN, Panda SS, Girgis AS, George RF, Farhat M, Katritzky AR. Synthesis and QSAR study of novel anti-inflammatory active mesalazine–metronidazole conjugates. Bioorg. Med. Chem. Lett. 25(11), 2314–2320 (2015).
   PubMed Web of Science ®Google Scholar
• Panda SS, Girgis AS, Honkanadavar HH, George RF, Srour AM. Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future Med. Chem. 12(15), 1369–1386 (2020).
   PubMed Web of Science ®Google Scholar
• Collirer HJ, Dinneen LC, Johnson CA, Scheider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother. 32(2), 295–310 (1968).
   PubMed Web of Science ®Google Scholar
• Finney DJ. Statistical Methods in Biological Assay (2nd Ed), Griffin, London, 597 (1964).
   Google Scholar
• Meshali M, El-Sabbagh E, Foda A. Effect of encapsulation of flufenamic acid with acrylic resins on its bioavailability and gastric ulcerogenic activity in rats. Acta Pharm. Technol. 29, 217–230 (1983).
   Google Scholar
• Robert A, Nezamis JE, Phillips JP. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology 55(4), 481–487 (1968).
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Stevans A, Turner DR. Theory and practice of histological techniques (4th Ed). Churchill Livingstone, Edinburgh, London, Melbourne, New York (1996).
   Google Scholar
• Boligon AA, Freitas RB, Brum TF et al. Antiulcerogenic activity of Scutiabuxifolia on gastric ulcers induced by ethanol in rats. Acta. Pharm. Sin. B 4(5), 358–367 (2014).
   PubMed Web of Science ®Google Scholar
• RCSB: Protein Data Bank [Internet]. RCSB. www.rcsb.org/
   Google Scholar
• Rimon G, Sidhu RS, Lauver DA, Smith WL. Crystal Structure of Cyclooxygenase-1 in complex with celecoxib. Proc. Natl. Acad. Sci. USA 107(1), 28–33 (2010).
   PubMed Web of Science ®Google Scholar
• Kiefer JR, Kurumbail RG, Stallings WC. Structureof celecoxib bound at the COX-2 active site RCSB: Protein Data Bank: RCSB: PDB. (2010). www.rcsb.org/structure/3ln1.
   Google Scholar
• Can NÖ, Osmaniye D, Levent S et al. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hmao-A inhibitors. Eur. J. Med. Chem. 144, 68–81 (2018).
   PubMed Web of Science ®Google Scholar
• Plöchl J. Über einige Derivate derBenzoylimidozimtsäure” [On some derivatives of benzoyl-imido-cinnaminic acid]. Berichte der deutschen chemischen Gesellschaft. 17(2), 1616–1624 (1884).
   Google Scholar
• Erlenmeyer F. Ueber die Condensation derHippursäure mit Phtalsäureanhydrid und mit Benzaldehyd". Annalen der Chemie. 275(1), 1–8 (1893).
   Google Scholar
• Bell EW, Zhang Y. Dockrmsd: an open-source toolfor atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J. Cheminform. 11(40), (2019).
   PubMedGoogle Scholar
• Shaikh MM, Patel AP, Patel SP, Chikhalia KH. Synthesis, in vitro COX-1/COX-2 inhibition testing and molecular docking study of novel 1,4-benzoxazine derivatives. New. J. Chem. 43(26), 10305–10317 (2019).
   Web of Science ®Google Scholar
• Dvorakova M, Langhansova L, Temml V, Pavicic A, Vanek T, Landa P. Synthesis, Inhibitory Activity, and In Silico Modeling of Selective COX–1 Inhibitors with a Quinazoline Core. ACS Med. Chem. Lett. 12(4), 610–616 (2021).
   PubMed Web of Science ®Google Scholar
• Kanamori K, Roberts JD. Nitrogen-15 NuclearMagnetic Resonance Study of Benzenesulfonamide and Cyanate Binding to Carbonic Anhydrase. Biochem. 22(11), 2658–2664 (1983).
   PubMed Web of Science ®Google Scholar
• Sisa M, Dvorakova M, Temml V, Jarosova V, Vanek T, Landa P. Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core. Eur. J. Med. Chem. 204, 112620 (2020).
   PubMed Web of Science ®Google Scholar